Ceftriaxone Absorption Enhancement for Noninvasive Administration as an Alternative to Injectable Solutions
Neonatal sepsis is a major cause of infant mortality in developing countries because of delayed injectable treatment, making it urgent to develop noninjectable formulations that can reduce treatment delays in resource-limited settings. Ceftriaxone, available only for injection, needs absorption enha...
Main Authors: | Ba, B, Gaudin, K, Désiré, A, Phoeung, T, Langlois, M, Behl, C, Unowsky, J, Patel, I, Malick, A, Gomes, M, White, N, Kauss, T |
---|---|
Format: | Journal article |
Sprog: | English |
Udgivet: |
American Society for Microbiology
2018
|
Lignende værker
-
Preformulation studies of ceftriaxone for pediatric non-parenteral administration as an alternative to existing injectable formulations
af: Kauss, T, et al.
Udgivet: (2017) -
Development of rectal self-emulsifying suspension of a moisture-labile water-soluble drug
af: Kauss, T, et al.
Udgivet: (2017) -
Development of rectodispersible tablets and granulate capsules for the treatment of serious neonatal sepsis in developing countries
af: Kauss, T, et al.
Udgivet: (2019) -
Screening paediatric rectal forms of azithromycin as an alternative to oral or injectable treatment.
af: Kauss, T, et al.
Udgivet: (2012) -
Validation process of EDTA for infusion/ injection with ceftriaxone and sulbactam
af: Md. Semimul Akhtar, et al.
Udgivet: (2021-09-01)